cefuroxime has been researched along with Arthritis, Degenerative in 2 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salavert, M | 1 |
| Navarro, V | 1 |
| Nelson, JD | 1 |
| Bucholz, RW | 1 |
| Kusmiesz, H | 1 |
| Shelton, S | 1 |
2 other studies available for cefuroxime and Arthritis, Degenerative
| Article | Year |
|---|---|
[Joint prosthesis infections: several comments].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacterial Infections; Bone | 2003 |
Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
Topics: Acute Disease; Administration, Oral; Arthritis, Infectious; Bacterial Infections; Cefaclor; Cefamand | 1982 |